NEW DELHI: Committees formed by government-owned Bharat Sanchar Nigam Limited (BSNL) for the technical evaluation of the bids received under the BharatNet Phase III ... PGM (BN-3), BSNL, and ...
BharatNet aims to provide broadband connectivity across rural India but faces delays and increased costs. Equipment worth ...
These telecom companies raised their prepaid and postpaid tariff plans by up to 15 percent on average, effective from July 3 ...
STATE Public Works Department Minister Rakesh Singh convened a meeting on Monday to discuss the vision document for West ...
More than two years after an initial FDA approval in melanoma, Bristol Myers Squibb is moving its PD-1/LAG-3 combo Opdualag ...
A multi-stage, clinical evolution process, culminating in a Phase 3 study confirmed the vaccine safety, immunogenicity and non-inferiority to existing OCVs, establishing its potential for white ...
BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...
Docetaxel remains the standard of care for patients with 2L/3L NSCLC without targetable alterations despite severe neutropenia (>40%) that greatly impair patients’ quality of life. Six recent phase 3 ...
RAHWAY, N.J., August 29, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630.
Sanofi is still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, executives have told Fierce Biotech, despite the BTK inhibitor falling short in two of three phase 3 trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback